2m 2m 2m 2m 2m 2m 2m
- N/AMarket Cap
- -23.42%1-Year Change
- Medical DevicesIndustry
Siem Healt Unsp ADR (SMMNY)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 4
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
The veterinary lab automation market is experiencing robust growth, expanding from $1.26 billion in 2025 to $1.36 billion in 2026 at an 8.4% CAGR, with projections to reach $1.9 billion by 2030. Growth is driven by rising demand for rapid diagnostics, AI integration, companion animal care expansion, and robotic workflow adoption. North America leads the market while Asia-Pacific is positioned for rapid expansion.
07/13/2026, 7:32 AM • GlobeNewswire
The global infant heart monitor market is projected to grow from USD 2.83 billion in 2025 to USD 7.93 billion by 2035, at a CAGR of 10.85%. Growth is driven by advancements in wearable medical technologies, rising adoption of remote monitoring, increased incidence of congenital heart defects, and expansion of healthcare infrastructure in emerging markets. North America leads the market while Asia-Pacific is expected to witness the fastest growth.
07/06/2026, 3:30 PM • GlobeNewswire
Bloodstream Infection Testing Market Size to Reach USD 1,404.68 Million by 2035 | SNS Insider
The global bloodstream infection testing market is expected to grow at a CAGR of 4.80% through 2035, driven by rising sepsis cases, antimicrobial stewardship mandates, and adoption of rapid molecular diagnostics. North America leads the market, with the U.S. contributing 87.4% of regional revenues, while Asia Pacific shows the fastest growth. Key technologies include molecular diagnostics and whole blood testing, which are rapidly replacing traditional blood culture methods.
06/26/2026, 4:30 AM • GlobeNewswire
The global laboratory equipment services market is projected to grow from USD 28.94 billion in 2025 to USD 62.83 billion by 2035, at a CAGR of 8%. Growth is driven by increased R&D investments in life sciences, stricter regulatory compliance requirements, expansion of biopharma facilities, and adoption of IoT-enhanced predictive maintenance technologies. Repair and maintenance services represent the largest market segment, with North America dominating and Asia Pacific showing the fastest growth.
06/24/2026, 3:30 PM • GlobeNewswire
Enteric Disease Testing Market Worth USD 5.86 Billion by 2035 | SNS Insider
The global Enteric Disease Testing Market is valued at USD 4.08 billion in 2025 and is projected to reach USD 5.86 billion by 2035, growing at a CAGR of 3.70%. Growth is driven by increasing foodborne and waterborne disease prevalence, rising demand for rapid pathogen detection, and expanding adoption of multiplex molecular diagnostics. North America and Europe are leading markets, with Asia-Pacific emerging as the fastest-growing region.
06/23/2026, 4:35 AM • GlobeNewswire
The global healthcare command centers market is projected to grow from USD 1.8 billion in 2024 to USD 5.0 billion by 2034, with a CAGR of 10.8%. Growth is driven by rising demand for efficient patient flow management, digital transformation in hospitals, and operational optimization. Cloud-based deployment dominates with 49% market share, while software components lead with 48% share. North America holds 41% of the global market. However, high implementation costs and limited adoption in developing regions pose challenges.
06/18/2026, 12:50 PM • GlobeNewswire
The global chemiluminescence immunoassay (CLIA) market is projected to grow from USD 11.58 billion in 2026 to USD 16.39 billion by 2031, with a CAGR of 7.2%. Growth is driven by rising demand for high-sensitivity diagnostic testing, automated laboratory systems, increasing prevalence of chronic and infectious diseases, and technological advancements including AI-enabled automation. Asia Pacific is emerging as a high-growth region, while hospitals lead market adoption.
06/05/2026, 10:30 AM • GlobeNewswire
Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight
The cervical cancer diagnostics market is projected to grow from USD 4.4 billion in 2025 to USD 7.1 billion by 2034 at a CAGR of ~5%. Growth is driven by rising cervical cancer prevalence, increasing adoption of advanced diagnostic technologies like HPV testing and AI-powered screening tools, government screening initiatives, and expanding healthcare infrastructure particularly in emerging economies. North America leads the market with 44% share in 2025.
05/14/2026, 1:00 PM • GlobeNewswire
The global colorectal cancer diagnostics and therapeutics market is projected to grow from USD 35 billion in 2025 to USD 73 billion by 2034 at a CAGR of ~9%. Growth is driven by rising colorectal cancer prevalence, increased screening awareness, advancements in non-invasive diagnostics (liquid biopsy, stool-based DNA tests), and emerging targeted therapies and immunotherapies. North America leads with 41% market share, while Asia-Pacific is the fastest-growing region.
05/13/2026, 1:00 PM • GlobeNewswire
Computer Vision in Healthcare Market Report 2026: Revenue Expected to Surpass $33.4 Billion by 2036
The global computer vision in healthcare market is projected to grow from $4.37 billion in 2026 to $33.4 billion by 2036, at a CAGR of 22.6%. Growth is driven by AI-integrated diagnostic systems, radiologist shortages, and precision medicine adoption. Software and medical imaging segments lead the market, while Asia-Pacific is expected to see the fastest regional growth.
05/08/2026, 9:53 AM • GlobeNewswire
The global pregnancy detection kits market is projected to grow from USD 1.91 billion in 2025 to USD 2.69 billion by 2031, with a CAGR of 5.87%. Growth is driven by technological advancements enabling earlier detection, rising infertility rates, and increasing adoption of digital integration and e-commerce distribution. However, the market faces challenges from accuracy concerns and user error risks that erode consumer trust.
05/08/2026, 4:47 AM • GlobeNewswire
The global coagulation analyzer market is projected to grow from USD 4.60 billion in 2025 to USD 7.87 billion by 2035, with a CAGR of 5.55%. Growth is driven by rising blood disorders, increasing surgeries, automation in diagnostics, and cardiovascular disease prevalence. The U.S. market alone is expected to grow from USD 1.50 billion to USD 2.41 billion. Consumables dominate with 64.28% market share, while fully automated systems show the fastest growth at 6.48% CAGR. Hospitals lead end-user segment with 52.84% share, and Asia-Pacific is the fastest-growing region at 7.24% CAGR.
04/22/2026, 10:00 AM • GlobeNewswire
The global allergy diagnostic market is expected to grow from USD 6.80 billion in 2025 to USD 10.77 billion by 2030, at a CAGR of 9.6%. Growth is driven by technological innovations such as multiplex immunoassays and molecular allergology, rising allergy incidence, and increasing awareness. North America leads the market, with major players including Thermo Fisher Scientific, Siemens Healthineers, and Danaher Corporation dominating the competitive landscape.
04/13/2026, 8:00 AM • GlobeNewswire
Radiopharm Theranostics and Siemens Healthineers announced a supply agreement for RAD101, a novel PET imaging agent for brain metastases. The Phase 2b interim analysis showed 90% concordance with MRI (primary endpoint), with significant tumor uptake. Siemens will manufacture and distribute 18F-labeled RAD101 to support the upcoming Phase 3 registrational trial in the U.S.
04/07/2026, 7:00 AM • GlobeNewswire
The IoT in healthcare market is projected to grow from USD 207.4 billion in 2026 to USD 483.72 billion by 2031, with a CAGR of 18.46%. Growth is driven by remote patient monitoring adoption, connected medical devices, digital health advancements, and declining sensor costs. North America leads the market while Asia-Pacific emerges as the fastest-growing region.
04/06/2026, 3:54 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 07/13/2026
Company Profile
SIEMENS HEALTHINEERS ADR
Key Executives
- Bernhard Montag
- Jochen Schmitz
- Darleen Caron
- Elisabeth Staudinger
- Astrid Kristine Ploss
Current Ownership Distribution
- Other1.1B (99.62%)
- Mutual Funds4.1M (0.37%)
- Institutions97,994 (0.009%)
- Insiders0 (0.00%)